1. IQVIA. The Use of Medicines in the U.S. n.d. https://www.iqvia.com/insights/the-iqvia-institute/reports/the-use-of-medicines-in-the-us (accessed October 25, 2022).
2. EMA. Investigation of bioequivalence - Scientific guideline. Eur Med Agency 2018. https://www.ema.europa.eu/en/investigation-bioequivalence-scientific-guideline (accessed December 21, 2022).
3. Research C for DE and. Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application. US Food Drug Adm 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioequivalence-studies-pharmacokinetic-endpoints-drugs-submitted-under-abbreviated-new-drug (accessed December 21, 2022).
4. The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry Perspectives;Anand;Pharm. Res.,2022
5. In Silico Modeling and Simulation to Guide Bioequivalence Testing for Oral Drugs in a Virtual Population;Zhang;Clin. Pharmacokinet.,2021